Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 May;35(5):1111-5.
doi: 10.1016/j.neurobiolaging.2013.11.001. Epub 2013 Nov 9.

Dysregulation of glucose metabolism is an early event in sporadic Parkinson's disease

Laura Dunn  1 , George Fg Allen  2 , Adamantios Mamais  3 , Helen Ling  4 , Abi Li  5 , Kate E Duberley  6 , Iain P Hargreaves  7 , Simon Pope  7 , Janice L Holton  5 , Andrew Lees  3 , Simon J Heales  8 , Rina Bandopadhyay  3
Affiliations

Dysregulation of glucose metabolism is an early event in sporadic Parkinson's disease

Laura Dunn et al. Neurobiol Aging. 2014 May.

Abstract

Unlike most other cell types, neurons preferentially metabolize glucose via the pentose phosphate pathway (PPP) to maintain their antioxidant status. Inhibiting the PPP in neuronal cell models causes cell death. In rodents, inhibition of this pathway causes selective dopaminergic cell death leading to motor deficits resembling parkinsonism. Using postmortem human brain tissue, we characterized glucose metabolism via the PPP in sporadic Parkinson's disease (PD), Alzheimer's disease (AD), and controls. AD brains showed increased nicotinamide adenine dinucleotide phosphate (NADPH) production in areas affected by disease. In PD however, increased NADPH production was only seen in the affected areas of late-stage cases. Quantifying PPP NADPH-producing enzymes glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase by enzyme-linked immunosorbent assay, showed a reduction in the putamen of early-stage PD and interestingly in the cerebellum of early and late-stage PD. Importantly, there was no decrease in enzyme levels in the cortex, putamen, or cerebellum of AD. Our results suggest that down-regulation of PPP enzymes and a failure to increase antioxidant reserve is an early event in the pathogenesis of sporadic PD.

Keywords: Glucose metabolism; NADPH; Neurodegeneration; Parkinson's disease; Pentose-phosphate pathway.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
(A) Total nicotinamide adenine dinucleotide phosphate (NADPH) produced by the pentose phosphate pathway. The combined activity of G6PD and 6PGD is shown. One mU is defined as 1 μmole NADPH produced/min/unit of enzyme. Activity is shown as the mean NADPH produced per unit expressed per mg total protein ± SEM. (B) G6PD enzyme levels. Levels of the G6PD enzyme were measured by enzyme-linked immunosorbent assay (ELISA) and the combined total shown here per mg total protein. (C) Efficiency of G6PD. The efficiency of G6PD was calculated by expressing the total NADPH measured per mg total protein, per ELISA unit (U) of G6PD. Relative activities are shown as mean NADPH produced per ELISA unit of protein ± SEM. Levels are shown as mean ± SEM. Con- pathologically normal controls, n = 13. Mild-McKeith brainstem predominant Parkinson's disease (PD) cases n = 11. Mod/Sev-McKeith limbic and diffuse neocortical cases. PD cases n = 12. Alzheimer's disease (AD) Braak and Braak stages IV-VI n = 13. Gray-cortex Brodmann area 4. Black-putamen. White-cerebellar vermis. One-way analysis of variance (ANOVA) significance p < 0.05, with Bonferroni posttest versus control * p < 0.05, ** p < 0.01, *** p < 0.001. Abbreviations: AD, Alzheimer's disease; ANOVA, analysis of variance; ELISA, enzyme-linked immunosorbent assay; NADPH, nicotinamide adenine dinucleotide phosphate; PD, Parkinson's disease; SEM, standard error of the mean.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Alam Z.I., Jenner A., Daniel S.E., Lees A.J., Cairns N., Marsden C.D., Jenner P., Halliwell B. Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra. J. Neurochem. 1997;69:1196–1203. - PubMed
    1. Ben-Yoseph O., Boxer P.A., Ross B.D. Oxidative stress in the central nervous system: monitoring the metabolic response using the pentose phosphate pathway. Dev. Neurosci. 1994;16:328–336. - PubMed
    1. Bolanos J.P., Heales S.J. Persistent mitochondrial damage by nitric oxide and its derivatives: neuropathological implications. Front Neuroenergetics. 2010;2 - PMC - PubMed
    1. Borghammer P. Perfusion and metabolism imaging studies in Parkinson's disease. Dan. Med. J. 2012;59:B4466. - PubMed
    1. Braak H., Del Tredici K., Rub U., de Vos R.A., Jansen Steur E.N., Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging. 2003;24:197–211. - PubMed

Publication types

MeSH terms